STOCK TITAN

UBS ETRACS Alerian MLP ETN Series B SEC Filings

AMUB NYSE

Welcome to our dedicated page for UBS ETRACS Alerian MLP ETN Series B SEC filings (Ticker: AMUB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The ETRACS Alerian MLP Index ETN Series B due July 18, 2042 (AMUB) is issued by UBS AG, a foreign private issuer that reports to the US Securities and Exchange Commission. UBS AG indicates that it files a registration statement on Form F-3, including a prospectus and supplements, for offerings of securities related to ETRACS ETNs such as AMUB. These documents set out the terms of the ETN and include a "Risk Factors" section that UBS urges investors to review before investing.

UBS AG also submits annual reports on Form 20-F and periodic reports on Form 6-K. In its Form 6-K filings, UBS provides information on capitalization, total debt issued, equity and other capital and liquidity metrics, as well as updates on regulatory developments and other corporate matters. UBS AG notes that its consolidated financial statements are prepared in accordance with IFRS Accounting Standards, and that certain 6-K reports are incorporated by reference into its Form F-3 registration statement.

For AMUB, the relevant SEC filings include the base prospectus, prospectus supplements and any pricing supplements that describe the specific terms of the ETRACS Alerian MLP Index ETN Series B. UBS’s public materials state that these offering documents are available through the SEC’s EDGAR system. They also clarify that the securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.

On this page, users can access AMUB-related SEC filings and associated issuer reports. The platform provides real-time updates from EDGAR and AI-powered summaries that explain the key points of lengthy documents, such as registration statements, prospectus supplements and UBS AG’s periodic reports. This allows investors to quickly identify disclosures that affect AMUB, including risk factor updates, capital and funding information, and other details relevant to UBS AG’s role as issuer of this senior unsecured ETN.

Rhea-AI Summary

UBS AG is offering unsecured Trigger Autocallable Contingent Yield Notes linked to the common stock of Vistra Corp., maturing on or about January 12, 2029. These notes pay a contingent coupon only on observation dates when Vistra’s stock closes at or above a preset coupon barrier; if the stock is below that level, no coupon is paid for that period.

The notes are automatically called early if, on any quarterly observation date before maturity, Vistra’s stock closes at or above the initial level. In that case, investors receive the principal plus any due contingent coupon, and the product terminates. If the notes are not called and, at maturity, Vistra’s stock is at or above a downside threshold, investors receive their full principal; if it is below that threshold, repayment is reduced in line with the stock’s decline and losses can reach 100% of principal. Any payment depends on the creditworthiness of UBS. The notes are not listed, have a minimum investment of 100 notes at $10 each, and have an estimated initial value between $9.35 and $9.60 per $10 note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering $100,000 of Trigger Autocallable Contingent Yield Notes linked to the common stock of Marvell Technology, Inc., maturing on January 12, 2029. Each Note has a principal amount of $10, with a minimum investment of 100 Notes ($1,000). UBS pays a contingent coupon only if the Marvell share price on an observation date is at or above a preset coupon barrier; otherwise no coupon is paid for that period.

The Notes are automatically called early if, on any monthly observation date after three months and before final valuation, the share price is at or above the initial level. In that case, investors receive principal plus the applicable contingent coupon and no further payments. If the Notes are not called and the final share price is at or above the downside threshold, investors receive principal back at maturity; if it is below the threshold, repayment is reduced in line with the stock decline and can fall to zero.

The Notes are unsecured, unsubordinated obligations of UBS, so all payments depend on UBS’s credit. They are not bank deposits, are not FDIC-insured, will not be listed on an exchange, and the estimated initial value per $10 Note is $9.65, reflecting UBS’s internal pricing models and funding costs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Marvell Technology, Inc., maturing around January 12, 2029. These are unsecured, unsubordinated debt obligations of UBS, not bank deposits and not FDIC insured.

Holders may receive periodic contingent coupons only if the stock closes at or above a coupon barrier on monthly observation dates. The notes can be automatically called after three months if the stock closes at or above its initial level, in which case investors receive the $10 principal per note plus any due coupon and no further payments.

If not called and the final stock level is at or above a downside threshold, investors receive the $10 principal at maturity, potentially with a final coupon. If the final level is below the downside threshold, repayment is reduced in line with the stock’s decline, and investors can lose all of their initial investment. All payments depend on UBS’s creditworthiness. The minimum investment is 100 notes at $10 each, and the estimated initial value per note is expected to be between $9.35 and $9.60.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG is offering $100,000 of Trigger Autocallable Contingent Yield Notes linked to the common stock of Advanced Micro Devices, Inc., maturing on January 12, 2028. These unsecured debt notes pay a contingent coupon only if AMD’s closing level on each observation date is at or above a coupon barrier set at 70% of the initial level; otherwise no coupon is paid.

The notes are automatically called if AMD is at or above its initial level on any observation date before maturity, returning principal plus the applicable contingent coupon, with no further payments. If not called, investors receive full principal at maturity only if AMD’s final level is at or above the downside threshold, also 70% of the initial level. If AMD finishes below that threshold, repayment is reduced in line with AMD’s negative return, and investors can lose all of their investment.

The hypothetical contingent coupon rate is 21.19% per annum100 notes at $10 each. The estimated initial value is $9.75 per $10 note, and all payments depend on the creditworthiness of UBS. The notes will not be listed on any exchange.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Advanced Micro Devices, Inc., maturing on or about January 12, 2028. These unsecured debt notes may pay a contingent coupon on each observation date only if AMD’s share price is at or above a preset coupon barrier; otherwise no coupon is paid for that period. The notes are automatically called early if AMD’s share price on any observation date before maturity is at or above the initial level, in which case investors receive principal plus the applicable coupon and no further payments.

If the notes are not called and AMD’s final share price is at or above the downside threshold, investors receive their full principal at maturity, potentially with a final coupon. If the final price is below the downside threshold, repayment is reduced in line with AMD’s decline, and all principal can be lost. All payments depend on the creditworthiness of UBS, and the notes will not be listed on any exchange.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering $7,716,500 of Trigger Autocallable Contingent Yield Notes linked to the worst performer of the SPDR S&P 500 ETF Trust (SPY) and the Energy Select Sector SPDR Fund (XLE), maturing in January 2029. The notes pay a contingent coupon at a 9.15% per annum rate only if on each quarterly observation date both ETFs close at or above their coupon barriers, set at 70% of their initial levels.

The notes can be called automatically after six months if both ETFs are at or above their full initial levels, returning principal plus any due coupon. If not called and both final ETF levels are at or above their 70% downside thresholds, investors receive back the $10 principal per note. If any ETF finishes below its downside threshold, repayment is reduced one-for-one with the loss of the worst-performing ETF, and investors can lose all principal. All payments depend on UBS’s creditworthiness.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG is offering $5,806,000 of Callable Contingent Interest Barrier Notes linked to the least performing of the Russell 2000 Index and the S&P 500 Index, each in $1,000 denominations. These 18‑month unsecured debt securities can pay a fixed contingent coupon of $7.2917 per month per Note, but only if on a given observation date both indices close at or above their interest barriers, set at 65% of their initial levels.

UBS may call the Notes on any monthly observation date (other than the final one), returning principal plus any due coupon and ending all future payments. If the Notes are not called and, at maturity, either index finishes below its 65% trigger level, investors receive their principal reduced one‑for‑one by the loss on the worst‑performing index and could lose their entire investment. All payments depend on UBS’s credit, the Notes are not insured or exchange‑listed, and the estimated initial value of $984.70 per $1,000 is below the issue price, reflecting fees and hedging costs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering $419,000 of Trigger Autocallable Contingent Yield Notes with Memory Interest linked to the least performing of the Nasdaq-100 Index®, iShares® Silver Trust and VanEck® Semiconductor ETF, maturing on January 10, 2031.

The Notes pay a 12.50% per annum contingent coupon (paid monthly) only if on a coupon observation date the closing level of each underlying is at or above its coupon barrier, set at 70% of its initial level. Missed coupons can be paid later if this condition is met, via the memory feature.

Starting after 12 months, the Notes are automatically called if all underlyings are at or above their call threshold levels, each at 100% of initial, returning principal plus due and unpaid coupons. If not called and any final level is below its 60% downside threshold, repayment is reduced one-for-one with the loss of the worst-performing underlying, and investors can lose all principal. The estimated initial value is $916.60 per $1,000 Note, and the Notes will not be listed, so liquidity may be limited. All payments depend on UBS’s credit.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering trigger callable contingent yield notes linked to three major U.S. equity indexes: the Nasdaq-100, Russell 2000 and S&P 500. The notes pay a contingent coupon at a rate of 9.90% per annum (about $8.25 per $1,000 note per month) only if on each observation date all three indexes are at or above their respective coupon barriers, set at 70% of their initial levels.

UBS can redeem the notes in whole, at its discretion, on any monthly observation date beginning after three months, returning principal plus any due coupon but ending all future payments. If the notes are not called and, at maturity, any index finishes below its downside threshold (also 70% of its initial level), investors lose principal one-for-one with the loss on the worst-performing index, up to a total loss. All payments depend on the creditworthiness of UBS, and the notes will not be listed on an exchange, with an estimated initial value between $958.10 and $988.10 per $1,000 note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG, through its London Branch, is offering Trigger Callable Contingent Yield Notes linked to the least performing of the Nasdaq-100 Technology Sector Index, the Russell 2000 Index and the S&P 500 Index, maturing around January 19, 2029. The Notes pay a monthly contingent coupon at a rate of 11.00% per annum (about $9.1667 per $1,000) only when the closing level of each index is at or above 70% of its initial level on the observation date. UBS can call the Notes in whole, beginning after three months, paying back principal plus any due coupon, ending all future payments.

If the Notes are not called and any index finishes below its 70% downside threshold at maturity, investors receive $1,000 multiplied by one plus the worst index return, which can mean a significant loss of principal, including total loss. The Notes are unsecured debt obligations of UBS, carry no principal protection unless all indices stay above their downside thresholds, and will not be listed on any exchange. The estimated initial value is expected between $955.40 and $985.40 per $1,000 issue price.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus

FAQ

How many UBS ETRACS Alerian MLP ETN Series B (AMUB) SEC filings are available on StockTitan?

StockTitan tracks 4411 SEC filings for UBS ETRACS Alerian MLP ETN Series B (AMUB), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for UBS ETRACS Alerian MLP ETN Series B (AMUB)?

The most recent SEC filing for UBS ETRACS Alerian MLP ETN Series B (AMUB) was filed on January 8, 2026.